FDA guidance aims to cut residual drug in delivery patches
FDA draft guidance published this week recommends manufacturers of drug delivery patches adopt QbD to minimise the amount of excess residual drug.
Archives for August 2, 2010
CRL & WuXi discuss Q2 results, life after collapse of deal
CRL and WuXi have both vowed to independently build their capabilities, to become integrated service providers, but reported mixed financial results.
Special Video Report
An exclusive look inside SAFC's HPAPI plant in Verona, Wisconsin
Greater recognition of toxicity risks of HPAPIs and continued growth of oncology sector are driving drug industry demand for safe manufacturing capacity says US fine molecules firm SAFC Pharma.
US patients call for Fabrazyme patent break; Are you watching Sanofi?
Calls for US government to break Genzyme’s Fabrazyme patents accompany more speculation that French drugmaker Sanofi Aventis is in takeover talks.
Bilcare to boost EU and US access with €100m Ineos Films buy
Bilcare to buy Ineos’ rigid polymer films business for €100m ($132m) to improve access to pharmaceutical packaging customers worldwide.